Steps toward the meaningful translation of prevention strategies for type 2 diabetes

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 663-665

  Cefalu, William T ^a,b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO;

AWARENESS; CONTROL STRATEGY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES EDUCATION; DIETARY INTAKE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HEALTH CARE ACCESS; HUMAN; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIMARY PREVENTION; QUALITY OF LIFE; STRATEGIC PLANNING; TREATMENT OUTCOME; WEIGHT CONTROL; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; METFORMIN; PREDIABETIC STATE; RISK REDUCTION BEHAVIOR; WEIGHT LOSS;

EID: 84862061034     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0119     Document Type: Editorial

References (11)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 (Internet), 2011. Atlanta, GA, U.S. Department of Health and Human Services. Available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2011. pdf. Accessed 19 January 2012
2. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403 (Pubitemid 34437694)
3. Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350 (Pubitemid 32378388)
4. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention ProgramOutcomes Study. Lancet 2009;374:1677-1686
5. American Diabetes Association. Our vision: life free of diabetes and all its burdens. 2012-2015 strategic plan (Internet), 2012. Alexandria, VA. Available from http://main.diabetes.org/dorg/PDFs/American-Diabetes-Association- 2012-2015-Strategic-Plan.pdf?-utma51.49302620.1326333141.1326333141.1326333141. 1&-utmb51.2.10. Accessed 19 January 2012
6. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-1575
7. The Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 2012;35:731-737
8. The Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723-730
9. Lachin JM, Christophi CA, Edelstein SL, et al.; DDK Research Group. Factors associated with diabetes onset during metformin versus placebo therapy in the Diabetes Prevention Program. Diabetes 2007;56:1153-1159 (Pubitemid 46525072)
10. Herman WH, Hoerger TJ, Brandle M, et al.; Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323-332 (Pubitemid 40293405)
11. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med 2005;143:251-264